Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021)

BioScience Health Innovations has reported Non-Current Debt over the past 2 years, most recently at $8713.0 for Q4 2021.

  • Quarterly Non-Current Debt rose 23.57% to $8713.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $8713.0 through Nov 2021, up 23.57% year-over-year, with the annual reading at $8713.0 for FY2021, 1046.45% up from the prior year.
  • Non-Current Debt was $8713.0 for Q4 2021 at BioScience Health Innovations, roughly flat from $8713.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $8713.0 in Q3 2021 and troughed at $760.0 in Q3 2020.